First trimester exposure to antiretroviral therapy and risk of birth defects.
AUTHORS
Phiri
K ,
Hernandez-Diaz
S ,
Dugan
KB ,
Williams
PL ,
Dudley
JA ,
Jules
A ,
Callahan
ST ,
Seage
GR ,
Cooper
WO ,
. The Pediatric infectious disease journal. 2014 7 ; 33(7). 741-6
- NIHMSID: 8701858
ABSTRACT
Use of antiretroviral (ARV) drugs during pregnancy has been associated with an increased risk of birth defects, but the evidence remains inconclusive.
Use of antiretroviral (ARV) drugs during pregnancy has been associated with an increased risk of birth defects, but the evidence remains inconclusive.
Tags: Faculty Publications 2014